Teratogenicity of zonisamide and other little-used antiseizure medications.
Seizure
; 117: 198-201, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38460459
ABSTRACT
PURPOSE:
To investigate the risk of teratogenesis occurring in relation to intrauterine exposure to infrequently used antiseizure medications in Australia.METHODS:
Analysis of data contained in the Raoul Wallenberg Australian Pregnancy Register of Antiepileptic Drugs.RESULTS:
There was statistically significant evidence that zonisamide, but not any other of nine infrequently used antiseizure medications in Australia, was associated with a risk of teratogenesis related to the maternal dose of the drug taken in at least the earlier half of pregnancy.CONCLUSIONS:
The teratogenesis associated with zonisamide, like that associated with topiramate and possibly acetazolamide, may be an expression of a class effect shared among sulphonamide-derived carbonic anhydrase inhibitors that possess anti-seizure activity.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Zonisamide
/
Anticonvulsants
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
Country/Region as subject:
Oceania
Language:
En
Journal:
Seizure
Journal subject:
NEUROLOGIA
Year:
2024
Type:
Article